UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Annals of oncology, 2013-03, Vol.24 (3), p.640-647

2013

Volltextzugriff (PDF)

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients

British journal of cancer, 2013-12, Vol.109 (12), p.2959-2964

2013

Volltextzugriff (PDF)

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

Annals of oncology, 2012-06, Vol.23 (6), p.1422-1427

2012

Volltextzugriff (PDF)

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

British journal of cancer, 2015-04, Vol.112 (8), p.1405-1410

2015

Volltextzugriff (PDF)

Prognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials

Annals of oncology, 2019-05, Vol.30, p.iii1-iii1

2019

Volltextzugriff (PDF)

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Cancer chemotherapy and pharmacology, 2013-01, Vol.71 (1), p.245-255

2013

Volltextzugriff (PDF)

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer

Annals of oncology, 2013-09, Vol.24 (9), p.2316-2324

2013

Volltextzugriff (PDF)

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence

Leukemia, 2009-05, Vol.23 (5), p.892-899

2009

Volltextzugriff (PDF)

Molecular signature of CD34 hematopoietic stem and progenitor cells of patients with CML in chronic phase

Leukemia, 2007-03, Vol.21 (3), p.494-504

2007

Volltextzugriff (PDF)

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

Breast cancer research and treatment, 2011-02, Vol.126 (1), p.109-117

2011

Volltextzugriff (PDF)

A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability

Nucleic acids research, 1999-11, Vol.27 (22), p.4328

1999

Volltextzugriff (PDF)

RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy

Annals of oncology, 2013-03, Vol.24 (3), p.632-639

2013

Volltextzugriff (PDF)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

British journal of cancer, 2012-11, Vol.107 (11), p.1892-1900

2012

Volltextzugriff (PDF)

Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy

Leukemia, 2009-05, Vol.23 (5), p.983-985

2009

Volltextzugriff (PDF)

Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab

Leukemia, 2005-11, Vol.19 (11), p.1993-1995

2005

Volltextzugriff (PDF)

P238 EndoPredict-based treatment decision can reduce chemotherapy usage in ER+, HER2− breast cancer

Breast (Edinburgh), 2015-03, Vol.24, p.S107-S107

2015

Volltextzugriff (PDF)

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Cancer chemotherapy and pharmacology, 2012-02, Vol.69 (2), p.533-546

2012

Volltextzugriff (PDF)

Abstract S4-3: The EndoPredict score identifies late distant metastases in ER+/HER2− breast cancer patients

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.S4-S4-3

2012

Volltextzugriff (PDF)

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

Bone marrow transplantation (Basingstoke), 2001-07, Vol.28 (1), p.47-49

2001

Volltextzugriff (PDF)

Abstract P3-08-01: Prognostic performance of EndoPredict in invasive lobular carcinoma

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-08-01

2018

Volltextzugriff (PDF)

Kinetic Selectivity of Complementary Nucleic Acids: bcr-abl-directed Antisense RNA and Ribozymes

Journal of molecular biology, 1996-06, Vol.259 (4), p.632-644

1996

Volltextzugriff (PDF)

The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

Cancer gene therapy, 2007-04, Vol.14 (4), p.431-439

2007

Volltextzugriff (PDF)

Abstract P4-08-05: Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-05

2019

Volltextzugriff (PDF)

Abstract OT1-12-03: RESCUE: Reaching for Evidence-baSed Chemotherapy Use in Endocrine sensitive breast cancer - A prospective health care study on risk assessment by the clinicomolecular test EndoPredict® and long-term patient outcome in early luminal breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-12-03-OT1-12-03

2019

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(113)
Japanisch
(17)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(72)
Science & Technology
(72)
Humans
(69)
Oncology
(43)
Biological And Medical Sciences
(38)
Female
(32)
Medical Sciences
(29)
Hematology
(28)
Middle Aged
(26)
Adult
(24)
Aged
(19)
Gene Expression
(16)
Male
(16)
Tumors
(16)
Prognosis
(15)
Gene Expression Profiling
(14)
Pharmacology. Drug Treatments
(13)
Breast Cancer
(12)
Breast Neoplasms - Genetics
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

Prognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence

Molecular signature of CD34 hematopoietic stem and progenitor cells of patients with CML in chronic phase

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability

RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer

Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy

Complete remission in a patient with relapsed angioimmunoblastic T-cell lymphoma following treatment with bevacizumab

P238 EndoPredict-based treatment decision can reduce chemotherapy usage in ER+, HER2− breast cancer

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Abstract S4-3: The EndoPredict score identifies late distant metastases in ER+/HER2− breast cancer patients

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

Abstract P3-08-01: Prognostic performance of EndoPredict in invasive lobular carcinoma

A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin κ C as a Compatible Prognostic Marker in Human Solid Tumors

Kinetic Selectivity of Complementary Nucleic Acids: bcr-abl-directed Antisense RNA and Ribozymes

The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

Abstract P4-08-05: Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years

Abstract OT1-12-03: RESCUE: Reaching for Evidence-baSed Chemotherapy Use in Endocrine sensitive breast cancer - A prospective health care study on risk assessment by the clinicomolecular test EndoPredict® and long-term patient outcome in early luminal breast cancer

Suchergebnisse filtern